Case Report: Gastrointestinal PEComa With TFE3 Rearrangement Treated With Anti-VEGFR TKI Apatinib

Case Report: Gastrointestinal PEComa With TFE3 Rearrangement Treated With Anti-VEGFR TKI Apatinib

Perivascular epithelioid cell tumors (PEComas) are rare mesenchymal tumors. Unresectable malignant PEComas with TFE3 rearrangement have no recommended therapy to date. Here, we report the first case of malignant gastrointestinal PEComa with TFE3 rearrangement which has a response to the targeted the...

Full description

Bibliographic Details
Main Authors: Jiaming Xu, Xiao-Lei Gong, Huanwen Wu, Lin Zhao
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-11-01
Series:Frontiers in Oncology
Subjects:
perivascular epithelioid cell tumors
TFE3
mammalian target of rapamycin inhibitor
anti-VEGFR
tyrosine kinase inhibitor
apatinib
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2020.582087/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2020.582087/full

Similar Items